Digital Therapeutics and Connected Care Market Size, Share, and Trends 2025 to 2034

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Digital Therapeutics & Connected Care Market 

5.1. COVID-19 Landscape: Digital Therapeutics & Connected Care Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Digital Therapeutics & Connected Care Market, By Application

8.1. Digital Therapeutics & Connected Care Market Revenue and Volume, by Application

8.1.1. Diabetes Management

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Mental Health (e.g., Depression, Anxiety, PTSD)

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Cardiovascular Diseases

8.1.3.1. Market Revenue and Volume Forecast

8.1.4. Respiratory Diseases (e.g., COPD, Asthma)

8.1.4.1. Market Revenue and Volume Forecast

8.1.5. Obesity & Weight Management

8.1.5.1. Market Revenue and Volume Forecast

8.1.6. Neurological Disorders (e.g., ADHD, Epilepsy)

8.1.6.1. Market Revenue and Volume Forecast

8.1.7. Smoking Cessation

8.1.7.1. Market Revenue and Volume Forecast

8.1.8. Substance Use Disorder

8.1.8.1. Market Revenue and Volume Forecast

8.1.9. Oncology Support

8.1.9.1. Market Revenue and Volume Forecast

8.1.10. Insomnia/Sleep Disorders

8.1.10.1. Market Revenue and Volume Forecast

8.1.11. Others

8.1.11.1. Market Revenue and Volume Forecast

Chapter 9. Global Digital Therapeutics & Connected Care Market, By Component

9.1. Digital Therapeutics & Connected Care Market Revenue and Volume, by Component

9.1.1. Software/Apps

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Devices

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Services 

9.1.3.1. Market Revenue and Volume Forecast

Chapter 10. Global Digital Therapeutics & Connected Care Market, By Therapeutic Approach 

10.1. Digital Therapeutics & Connected Care Market Revenue and Volume, by Therapeutic Approach

10.1.1. Cognitive Behavioral Therapy (CBT)-based Solutions

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Biofeedback & Gamification

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. AI-based Personalized Interventions

10.1.3.1. Market Revenue and Volume Forecast

10.1.4. Mindfulness & Meditation

10.1.4.1. Market Revenue and Volume Forecast

10.1.5. Habit-Reinforcement Platforms

10.1.5.1. Market Revenue and Volume Forecast

Chapter 11. Global Digital Therapeutics & Connected Care Market, By Business Model

11.1. Digital Therapeutics & Connected Care Market Revenue and Volume, by Business Model

11.1.1. Business-to-Consumer (B2C)

11.1.1.1. Market Revenue and Volume Forecast

11.1.2. Business-to-Business (B2B)

11.1.2.1. Market Revenue and Volume Forecast

11.1.3. B2B2C

11.1.3.1. Market Revenue and Volume Forecast

Chapter 12. Global Digital Therapeutics & Connected Care Market, By End User

12.1. Digital Therapeutics & Connected Care Market Revenue and Volume, by End User

12.1.1. Patients (Self-managed care)

12.1.1.1. Market Revenue and Volume Forecast

12.1.2. Providers (Hospitals, Clinics, Specialists)

12.1.2.1. Market Revenue and Volume Forecast

12.1.3. Payers (Insurers, Employers)

12.1.3.1. Market Revenue and Volume Forecast

12.1.4. Research & Academic Institutions

12.1.4.1. Market Revenue and Volume Forecast

Chapter 13. Global Digital Therapeutics & Connected Care Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Volume Forecast, by Application

13.1.2. Market Revenue and Volume Forecast, by Component

13.1.3. Market Revenue and Volume Forecast, by Therapeutic Approach

13.1.4. Market Revenue and Volume Forecast, by Business Model

13.1.5. Market Revenue and Volume Forecast, by End User

13.1.6. U.S.

13.1.6.1. Market Revenue and Volume Forecast, by Application

13.1.6.2. Market Revenue and Volume Forecast, by Component

13.1.6.3. Market Revenue and Volume Forecast, by Therapeutic Approach

13.1.6.4. Market Revenue and Volume Forecast, by Business Model

13.1.6.5. Market Revenue and Volume Forecast, by End User  

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Volume Forecast, by Application

13.1.7.2. Market Revenue and Volume Forecast, by Component

13.1.7.3. Market Revenue and Volume Forecast, by Therapeutic Approach

13.1.7.4. Market Revenue and Volume Forecast, by Business Model

13.1.7.5. Market Revenue and Volume Forecast, by End User

13.2. Europe

13.2.1. Market Revenue and Volume Forecast, by Application

13.2.2. Market Revenue and Volume Forecast, by Component

13.2.3. Market Revenue and Volume Forecast, by Therapeutic Approach

13.2.4. Market Revenue and Volume Forecast, by Business Model  

13.2.5. Market Revenue and Volume Forecast, by End User  

13.2.6. UK

13.2.6.1. Market Revenue and Volume Forecast, by Application

13.2.6.2. Market Revenue and Volume Forecast, by Component

13.2.6.3. Market Revenue and Volume Forecast, by Therapeutic Approach

13.2.7. Market Revenue and Volume Forecast, by Business Model  

13.2.8. Market Revenue and Volume Forecast, by End User  

13.2.9. Germany

13.2.9.1. Market Revenue and Volume Forecast, by Application

13.2.9.2. Market Revenue and Volume Forecast, by Component

13.2.9.3. Market Revenue and Volume Forecast, by Therapeutic Approach

13.2.10. Market Revenue and Volume Forecast, by Business Model

13.2.11. Market Revenue and Volume Forecast, by End User

13.2.12. France

13.2.12.1. Market Revenue and Volume Forecast, by Application

13.2.12.2. Market Revenue and Volume Forecast, by Component

13.2.12.3. Market Revenue and Volume Forecast, by Therapeutic Approach

13.2.12.4. Market Revenue and Volume Forecast, by Business Model

13.2.13. Market Revenue and Volume Forecast, by End User

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Volume Forecast, by Application

13.2.14.2. Market Revenue and Volume Forecast, by Component

13.2.14.3. Market Revenue and Volume Forecast, by Therapeutic Approach

13.2.14.4. Market Revenue and Volume Forecast, by Business Model

13.2.15. Market Revenue and Volume Forecast, by End User

13.3. APAC

13.3.1. Market Revenue and Volume Forecast, by Application

13.3.2. Market Revenue and Volume Forecast, by Component

13.3.3. Market Revenue and Volume Forecast, by Therapeutic Approach

13.3.4. Market Revenue and Volume Forecast, by Business Model

13.3.5. Market Revenue and Volume Forecast, by End User

13.3.6. India

13.3.6.1. Market Revenue and Volume Forecast, by Application

13.3.6.2. Market Revenue and Volume Forecast, by Component

13.3.6.3. Market Revenue and Volume Forecast, by Therapeutic Approach

13.3.6.4. Market Revenue and Volume Forecast, by Business Model

13.3.7. Market Revenue and Volume Forecast, by End User

13.3.8. China

13.3.8.1. Market Revenue and Volume Forecast, by Application

13.3.8.2. Market Revenue and Volume Forecast, by Component

13.3.8.3. Market Revenue and Volume Forecast, by Therapeutic Approach

13.3.8.4. Market Revenue and Volume Forecast, by Business Model

13.3.9. Market Revenue and Volume Forecast, by End User

13.3.10. Japan

13.3.10.1. Market Revenue and Volume Forecast, by Application

13.3.10.2. Market Revenue and Volume Forecast, by Component

13.3.10.3. Market Revenue and Volume Forecast, by Therapeutic Approach

13.3.10.4. Market Revenue and Volume Forecast, by Business Model

13.3.10.5. Market Revenue and Volume Forecast, by End User

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Volume Forecast, by Application

13.3.11.2. Market Revenue and Volume Forecast, by Component

13.3.11.3. Market Revenue and Volume Forecast, by Therapeutic Approach

13.3.11.4. Market Revenue and Volume Forecast, by Business Model

13.3.11.5. Market Revenue and Volume Forecast, by End User

13.4. MEA

13.4.1. Market Revenue and Volume Forecast, by Application

13.4.2. Market Revenue and Volume Forecast, by Component

13.4.3. Market Revenue and Volume Forecast, by Therapeutic Approach

13.4.4. Market Revenue and Volume Forecast, by Business Model

13.4.5. Market Revenue and Volume Forecast, by End User

13.4.6. GCC

13.4.6.1. Market Revenue and Volume Forecast, by Application

13.4.6.2. Market Revenue and Volume Forecast, by Component

13.4.6.3. Market Revenue and Volume Forecast, by Therapeutic Approach

13.4.6.4. Market Revenue and Volume Forecast, by Business Model

13.4.7. Market Revenue and Volume Forecast, by End User

13.4.8. North Africa

13.4.8.1. Market Revenue and Volume Forecast, by Application

13.4.8.2. Market Revenue and Volume Forecast, by Component

13.4.8.3. Market Revenue and Volume Forecast, by Therapeutic Approach

13.4.8.4. Market Revenue and Volume Forecast, by Business Model

13.4.9. Market Revenue and Volume Forecast, by End User

13.4.10. South Africa

13.4.10.1. Market Revenue and Volume Forecast, by Application

13.4.10.2. Market Revenue and Volume Forecast, by Component

13.4.10.3. Market Revenue and Volume Forecast, by Therapeutic Approach

13.4.10.4. Market Revenue and Volume Forecast, by Business Model

13.4.10.5. Market Revenue and Volume Forecast, by End User

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Volume Forecast, by Application

13.4.11.2. Market Revenue and Volume Forecast, by Component

13.4.11.3. Market Revenue and Volume Forecast, by Therapeutic Approach

13.4.11.4. Market Revenue and Volume Forecast, by Business Model

13.4.11.5. Market Revenue and Volume Forecast, by End User

13.5. Latin America

13.5.1. Market Revenue and Volume Forecast, by Application

13.5.2. Market Revenue and Volume Forecast, by Component

13.5.3. Market Revenue and Volume Forecast, by Therapeutic Approach

13.5.4. Market Revenue and Volume Forecast, by Business Model

13.5.5. Market Revenue and Volume Forecast, by End User

13.5.6. Brazil

13.5.6.1. Market Revenue and Volume Forecast, by Application

13.5.6.2. Market Revenue and Volume Forecast, by Component

13.5.6.3. Market Revenue and Volume Forecast, by Therapeutic Approach

13.5.6.4. Market Revenue and Volume Forecast, by Business Model

13.5.7. Market Revenue and Volume Forecast, by End User

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Volume Forecast, by Application

13.5.8.2. Market Revenue and Volume Forecast, by Component

13.5.8.3. Market Revenue and Volume Forecast, by Therapeutic Approach

13.5.8.4. Market Revenue and Volume Forecast, by Business Model

13.5.8.5. Market Revenue and Volume Forecast, by End User

Chapter 14. Company Profiles

14.1. Omada Health

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Livongo Health (Teladoc Health)

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Big Health

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Propeller Health (ResMed)

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Happify Health

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Kaia Health

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Voluntis (AptarGroup)

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Better Therapeutics

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Click Therapeutics

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms